Multinational firms to benefit from new drug reform

Published: 2011-05-26 07:00:00

Updated: 2011-05-26 07:00:00

Most of foreign-invested drug firms are expected to increase their drug sales under the current system that has made doctors and pharmacists as well as pharmaceutical firms subject to punishment if they are found to have been involved in illegal deals, according to market watchers.

These compa...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK